Off-label use of anti-cancer drugs between clinical practice and research: the Italian experience View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2012-05

AUTHORS

Rosa Lerose, Pellegrino Musto, Michele Aieta, Carla Papa, Alfredo Tartarone

ABSTRACT

BACKGROUND: Off-label use is the practice of prescribing a drug outside the terms of its official labeling. Worldwide, about 20% of the commonly prescribed medications are off-label, and the percentage increases in specific patient populations, such as children, pregnant women, and cancer patients. Off-label use is particularly widespread in oncology for many reasons, including the wide variety of cancer subtypes, the difficulties involved in performing clinical trials, the rapid diffusion of preliminary results, and delays in the approval of new drugs by regulatory organizations/agencies. OBJECTIVE: The aim of this article is to describe the use of off-label drugs in oncology, with an emphasis on the role of the world's leading regulatory agencies and an assessment of current Italian legislation. CONCLUSION: Off-label drug utilization is essential in oncology when based on evidence. However, off-label drugs must be prescribed in accordance with existing national laws and only when the potential benefit outweighs the potential toxic effects. More... »

PAGES

505-512

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00228-011-1173-6

DOI

http://dx.doi.org/10.1007/s00228-011-1173-6

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1029224257

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/22166932


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Compassionate Use Trials", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Approval", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Costs", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drugs, Investigational", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "European Union", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Evidence-Based Medicine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Government Agencies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Italy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Legislation, Drug", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Off-Label Use", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Reimbursement Mechanisms", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "Hospital Pharmacy, I.R.C.C.S. Centro di Riferimento Oncologico di Basilicata, Via Padre Pio 1, 85028, Rionero in Vulture, PZ, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lerose", 
        "givenName": "Rosa", 
        "id": "sg:person.01326737537.34", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01326737537.34"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centro di Riferimento Oncologico della Basilicata", 
          "id": "https://www.grid.ac/institutes/grid.418322.e", 
          "name": [
            "Department of Onco-Hematology, I.R.C.C.S. Centro di Riferimento Oncologico di Basilicata, Rionero in Vulture, PZ, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Musto", 
        "givenName": "Pellegrino", 
        "id": "sg:person.01176100006.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01176100006.15"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centro di Riferimento Oncologico della Basilicata", 
          "id": "https://www.grid.ac/institutes/grid.418322.e", 
          "name": [
            "Department of Onco-Hematology, I.R.C.C.S. Centro di Riferimento Oncologico di Basilicata, Rionero in Vulture, PZ, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Aieta", 
        "givenName": "Michele", 
        "id": "sg:person.01327331765.77", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01327331765.77"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Hospital Pharmacy, I.R.C.C.S. Centro di Riferimento Oncologico di Basilicata, Via Padre Pio 1, 85028, Rionero in Vulture, PZ, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Papa", 
        "givenName": "Carla", 
        "id": "sg:person.01034010437.75", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01034010437.75"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centro di Riferimento Oncologico della Basilicata", 
          "id": "https://www.grid.ac/institutes/grid.418322.e", 
          "name": [
            "Department of Onco-Hematology, I.R.C.C.S. Centro di Riferimento Oncologico di Basilicata, Rionero in Vulture, PZ, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tartarone", 
        "givenName": "Alfredo", 
        "id": "sg:person.01275740611.92", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01275740611.92"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1634/theoncologist.2010-s1-58", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004219720"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdm517", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006759230"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa0908127", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010192285"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdg031", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013830509"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa052306", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014794593"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa052306", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014794593"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11096-011-9537-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022707179", 
          "https://doi.org/10.1007/s11096-011-9537-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2006.06.8940", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030184862"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3109/07357909109018958", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030428216"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00002018-200225010-00001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030810498", 
          "https://doi.org/10.2165/00002018-200225010-00001"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00002018-200225010-00001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030810498", 
          "https://doi.org/10.2165/00002018-200225010-00001"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00520-004-0593-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031494201", 
          "https://doi.org/10.1007/s00520-004-0593-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2010.34.1248", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031741399"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa072113", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033842397"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa052122", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035589584"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa052122", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035589584"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00120-006-1223-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035657459", 
          "https://doi.org/10.1007/s00120-006-1223-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00120-006-1223-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035657459", 
          "https://doi.org/10.1007/s00120-006-1223-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmhpr0807774", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040038659"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2009.26.2758", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042800800"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejca.2008.11.040", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044460796"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmp0802107", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046285446"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(08)70280-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048332383"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2008.16.9599", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051285514"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11096-011-9532-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052150722", 
          "https://doi.org/10.1007/s11096-011-9532-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/94.22.1668", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059820988"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00042560-199605010-00008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060296025"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmj.a3182", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062800786"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmj.a3182", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062800786"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1075285452", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1075334282", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077061064", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077326340", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.5694/j.1326-5377.2006.tb00689.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1077326340"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/030089160909500601", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078058240"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/030089160909500601", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078058240"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078435994", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082502532", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2012-05", 
    "datePublishedReg": "2012-05-01", 
    "description": "BACKGROUND: Off-label use is the practice of prescribing a drug outside the terms of its official labeling. Worldwide, about 20% of the commonly prescribed medications are off-label, and the percentage increases in specific patient populations, such as children, pregnant women, and cancer patients. Off-label use is particularly widespread in oncology for many reasons, including the wide variety of cancer subtypes, the difficulties involved in performing clinical trials, the rapid diffusion of preliminary results, and delays in the approval of new drugs by regulatory organizations/agencies.\nOBJECTIVE: The aim of this article is to describe the use of off-label drugs in oncology, with an emphasis on the role of the world's leading regulatory agencies and an assessment of current Italian legislation.\nCONCLUSION: Off-label drug utilization is essential in oncology when based on evidence. However, off-label drugs must be prescribed in accordance with existing national laws and only when the potential benefit outweighs the potential toxic effects.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00228-011-1173-6", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1054337", 
        "issn": [
          "0031-6970", 
          "1432-1041"
        ], 
        "name": "European Journal of Clinical Pharmacology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "5", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "68"
      }
    ], 
    "name": "Off-label use of anti-cancer drugs between clinical practice and research: the Italian experience", 
    "pagination": "505-512", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "8b38a0aed28f6a5942bd8f24f5caa4329b4b421204d1876941e3e5eea8fdf8d2"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "22166932"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "1256165"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00228-011-1173-6"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1029224257"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00228-011-1173-6", 
      "https://app.dimensions.ai/details/publication/pub.1029224257"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T16:42", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8669_00000513.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs00228-011-1173-6"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00228-011-1173-6'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00228-011-1173-6'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00228-011-1173-6'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00228-011-1173-6'


 

This table displays all metadata directly associated to this object as RDF triples.

252 TRIPLES      21 PREDICATES      75 URIs      35 LITERALS      23 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00228-011-1173-6 schema:about N049ad7f806d545f983aa67d2e6599213
2 N12139ee25c3b447ab25ea5782da64583
3 N188d88f15bd140ae8d40ec06091e3d79
4 N243ae5a1fc404a6fa875d4b82c251719
5 N27214ec0cae846448712011c544e0e20
6 N3cc0e2a69b3b40a694d3f3e7feca5691
7 N4a81d8ab149042ac997b594b6177627b
8 N690df0eaca214aa282b9dee4f7b57351
9 N6b74deac3b1c4c65854feca0810d22aa
10 N87eceb0a5b4e46039edd2440ed2b04cd
11 N8ff25317e6bb4d56b0b9b7ce1cf98cec
12 N957f37d212f94beb847e8f882c3f9d2c
13 Nbf5e0ce0a37f438bab27418a857ee16f
14 Ne00fab1ca1d745f596c91b63eb1ccd5b
15 anzsrc-for:11
16 anzsrc-for:1112
17 schema:author N61e5ed77ed304d43b03c03365c7d1798
18 schema:citation sg:pub.10.1007/s00120-006-1223-3
19 sg:pub.10.1007/s00520-004-0593-6
20 sg:pub.10.1007/s11096-011-9532-z
21 sg:pub.10.1007/s11096-011-9537-7
22 sg:pub.10.2165/00002018-200225010-00001
23 https://app.dimensions.ai/details/publication/pub.1075285452
24 https://app.dimensions.ai/details/publication/pub.1075334282
25 https://app.dimensions.ai/details/publication/pub.1077061064
26 https://app.dimensions.ai/details/publication/pub.1077326340
27 https://app.dimensions.ai/details/publication/pub.1078435994
28 https://app.dimensions.ai/details/publication/pub.1082502532
29 https://doi.org/10.1016/j.ejca.2008.11.040
30 https://doi.org/10.1016/s1470-2045(08)70280-8
31 https://doi.org/10.1056/nejmhpr0807774
32 https://doi.org/10.1056/nejmoa052122
33 https://doi.org/10.1056/nejmoa052306
34 https://doi.org/10.1056/nejmoa072113
35 https://doi.org/10.1056/nejmoa0908127
36 https://doi.org/10.1056/nejmp0802107
37 https://doi.org/10.1093/annonc/mdg031
38 https://doi.org/10.1093/annonc/mdm517
39 https://doi.org/10.1093/jnci/94.22.1668
40 https://doi.org/10.1097/00042560-199605010-00008
41 https://doi.org/10.1136/bmj.a3182
42 https://doi.org/10.1177/030089160909500601
43 https://doi.org/10.1200/jco.2006.06.8940
44 https://doi.org/10.1200/jco.2008.16.9599
45 https://doi.org/10.1200/jco.2009.26.2758
46 https://doi.org/10.1200/jco.2010.34.1248
47 https://doi.org/10.1634/theoncologist.2010-s1-58
48 https://doi.org/10.3109/07357909109018958
49 https://doi.org/10.5694/j.1326-5377.2006.tb00689.x
50 schema:datePublished 2012-05
51 schema:datePublishedReg 2012-05-01
52 schema:description BACKGROUND: Off-label use is the practice of prescribing a drug outside the terms of its official labeling. Worldwide, about 20% of the commonly prescribed medications are off-label, and the percentage increases in specific patient populations, such as children, pregnant women, and cancer patients. Off-label use is particularly widespread in oncology for many reasons, including the wide variety of cancer subtypes, the difficulties involved in performing clinical trials, the rapid diffusion of preliminary results, and delays in the approval of new drugs by regulatory organizations/agencies. OBJECTIVE: The aim of this article is to describe the use of off-label drugs in oncology, with an emphasis on the role of the world's leading regulatory agencies and an assessment of current Italian legislation. CONCLUSION: Off-label drug utilization is essential in oncology when based on evidence. However, off-label drugs must be prescribed in accordance with existing national laws and only when the potential benefit outweighs the potential toxic effects.
53 schema:genre research_article
54 schema:inLanguage en
55 schema:isAccessibleForFree false
56 schema:isPartOf N43e6d64243c04c5fa0624bfeb740930f
57 N510ae24750f94ecdaf15538fcd4d9847
58 sg:journal.1054337
59 schema:name Off-label use of anti-cancer drugs between clinical practice and research: the Italian experience
60 schema:pagination 505-512
61 schema:productId N123cb5116ac242b8aafc200225190a96
62 N47bdc3cb842d47ae987ceea40dd31f00
63 Na615e242d9f04530916fd02c9b77aed4
64 Nd3e7959565214993b931e8e57cc8f44c
65 Nd8640d55c2d6483299873d4ec26bd665
66 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029224257
67 https://doi.org/10.1007/s00228-011-1173-6
68 schema:sdDatePublished 2019-04-10T16:42
69 schema:sdLicense https://scigraph.springernature.com/explorer/license/
70 schema:sdPublisher N39bc3d6371524df2bd51f79ecb766646
71 schema:url http://link.springer.com/10.1007%2Fs00228-011-1173-6
72 sgo:license sg:explorer/license/
73 sgo:sdDataset articles
74 rdf:type schema:ScholarlyArticle
75 N01c9dca71bb74b6ca174d1db80837802 rdf:first sg:person.01275740611.92
76 rdf:rest rdf:nil
77 N049ad7f806d545f983aa67d2e6599213 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
78 schema:name Off-Label Use
79 rdf:type schema:DefinedTerm
80 N12139ee25c3b447ab25ea5782da64583 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
81 schema:name Drug Costs
82 rdf:type schema:DefinedTerm
83 N123cb5116ac242b8aafc200225190a96 schema:name doi
84 schema:value 10.1007/s00228-011-1173-6
85 rdf:type schema:PropertyValue
86 N188d88f15bd140ae8d40ec06091e3d79 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
87 schema:name Drugs, Investigational
88 rdf:type schema:DefinedTerm
89 N243ae5a1fc404a6fa875d4b82c251719 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
90 schema:name Italy
91 rdf:type schema:DefinedTerm
92 N27214ec0cae846448712011c544e0e20 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
93 schema:name Compassionate Use Trials
94 rdf:type schema:DefinedTerm
95 N39bc3d6371524df2bd51f79ecb766646 schema:name Springer Nature - SN SciGraph project
96 rdf:type schema:Organization
97 N3cc0e2a69b3b40a694d3f3e7feca5691 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Antineoplastic Agents
99 rdf:type schema:DefinedTerm
100 N43e6d64243c04c5fa0624bfeb740930f schema:issueNumber 5
101 rdf:type schema:PublicationIssue
102 N47bdc3cb842d47ae987ceea40dd31f00 schema:name pubmed_id
103 schema:value 22166932
104 rdf:type schema:PropertyValue
105 N4a81d8ab149042ac997b594b6177627b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Government Agencies
107 rdf:type schema:DefinedTerm
108 N4cff7ad5baec4200bb08d195d19a26df rdf:first sg:person.01034010437.75
109 rdf:rest N01c9dca71bb74b6ca174d1db80837802
110 N510ae24750f94ecdaf15538fcd4d9847 schema:volumeNumber 68
111 rdf:type schema:PublicationVolume
112 N6028e5c825a14f63b201cdece1020a16 rdf:first sg:person.01327331765.77
113 rdf:rest N4cff7ad5baec4200bb08d195d19a26df
114 N61e5ed77ed304d43b03c03365c7d1798 rdf:first sg:person.01326737537.34
115 rdf:rest Nd5f3cf4aaf9b478991e22cc1c1277752
116 N690df0eaca214aa282b9dee4f7b57351 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Reimbursement Mechanisms
118 rdf:type schema:DefinedTerm
119 N6b74deac3b1c4c65854feca0810d22aa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Drug Approval
121 rdf:type schema:DefinedTerm
122 N770ea3f0e18949479fa1a92f0b30d910 schema:name Hospital Pharmacy, I.R.C.C.S. Centro di Riferimento Oncologico di Basilicata, Via Padre Pio 1, 85028, Rionero in Vulture, PZ, Italy
123 rdf:type schema:Organization
124 N87eceb0a5b4e46039edd2440ed2b04cd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name European Union
126 rdf:type schema:DefinedTerm
127 N8ff25317e6bb4d56b0b9b7ce1cf98cec schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Legislation, Drug
129 rdf:type schema:DefinedTerm
130 N957f37d212f94beb847e8f882c3f9d2c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Evidence-Based Medicine
132 rdf:type schema:DefinedTerm
133 Na61568d613a2420a9699df1cf2ff0d9e schema:name Hospital Pharmacy, I.R.C.C.S. Centro di Riferimento Oncologico di Basilicata, Via Padre Pio 1, 85028, Rionero in Vulture, PZ, Italy
134 rdf:type schema:Organization
135 Na615e242d9f04530916fd02c9b77aed4 schema:name nlm_unique_id
136 schema:value 1256165
137 rdf:type schema:PropertyValue
138 Nbf5e0ce0a37f438bab27418a857ee16f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Humans
140 rdf:type schema:DefinedTerm
141 Nd3e7959565214993b931e8e57cc8f44c schema:name readcube_id
142 schema:value 8b38a0aed28f6a5942bd8f24f5caa4329b4b421204d1876941e3e5eea8fdf8d2
143 rdf:type schema:PropertyValue
144 Nd5f3cf4aaf9b478991e22cc1c1277752 rdf:first sg:person.01176100006.15
145 rdf:rest N6028e5c825a14f63b201cdece1020a16
146 Nd8640d55c2d6483299873d4ec26bd665 schema:name dimensions_id
147 schema:value pub.1029224257
148 rdf:type schema:PropertyValue
149 Ne00fab1ca1d745f596c91b63eb1ccd5b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Neoplasms
151 rdf:type schema:DefinedTerm
152 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
153 schema:name Medical and Health Sciences
154 rdf:type schema:DefinedTerm
155 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
156 schema:name Oncology and Carcinogenesis
157 rdf:type schema:DefinedTerm
158 sg:journal.1054337 schema:issn 0031-6970
159 1432-1041
160 schema:name European Journal of Clinical Pharmacology
161 rdf:type schema:Periodical
162 sg:person.01034010437.75 schema:affiliation N770ea3f0e18949479fa1a92f0b30d910
163 schema:familyName Papa
164 schema:givenName Carla
165 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01034010437.75
166 rdf:type schema:Person
167 sg:person.01176100006.15 schema:affiliation https://www.grid.ac/institutes/grid.418322.e
168 schema:familyName Musto
169 schema:givenName Pellegrino
170 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01176100006.15
171 rdf:type schema:Person
172 sg:person.01275740611.92 schema:affiliation https://www.grid.ac/institutes/grid.418322.e
173 schema:familyName Tartarone
174 schema:givenName Alfredo
175 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01275740611.92
176 rdf:type schema:Person
177 sg:person.01326737537.34 schema:affiliation Na61568d613a2420a9699df1cf2ff0d9e
178 schema:familyName Lerose
179 schema:givenName Rosa
180 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01326737537.34
181 rdf:type schema:Person
182 sg:person.01327331765.77 schema:affiliation https://www.grid.ac/institutes/grid.418322.e
183 schema:familyName Aieta
184 schema:givenName Michele
185 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01327331765.77
186 rdf:type schema:Person
187 sg:pub.10.1007/s00120-006-1223-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035657459
188 https://doi.org/10.1007/s00120-006-1223-3
189 rdf:type schema:CreativeWork
190 sg:pub.10.1007/s00520-004-0593-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031494201
191 https://doi.org/10.1007/s00520-004-0593-6
192 rdf:type schema:CreativeWork
193 sg:pub.10.1007/s11096-011-9532-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1052150722
194 https://doi.org/10.1007/s11096-011-9532-z
195 rdf:type schema:CreativeWork
196 sg:pub.10.1007/s11096-011-9537-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022707179
197 https://doi.org/10.1007/s11096-011-9537-7
198 rdf:type schema:CreativeWork
199 sg:pub.10.2165/00002018-200225010-00001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030810498
200 https://doi.org/10.2165/00002018-200225010-00001
201 rdf:type schema:CreativeWork
202 https://app.dimensions.ai/details/publication/pub.1075285452 schema:CreativeWork
203 https://app.dimensions.ai/details/publication/pub.1075334282 schema:CreativeWork
204 https://app.dimensions.ai/details/publication/pub.1077061064 schema:CreativeWork
205 https://app.dimensions.ai/details/publication/pub.1077326340 schema:CreativeWork
206 https://app.dimensions.ai/details/publication/pub.1078435994 schema:CreativeWork
207 https://app.dimensions.ai/details/publication/pub.1082502532 schema:CreativeWork
208 https://doi.org/10.1016/j.ejca.2008.11.040 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044460796
209 rdf:type schema:CreativeWork
210 https://doi.org/10.1016/s1470-2045(08)70280-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048332383
211 rdf:type schema:CreativeWork
212 https://doi.org/10.1056/nejmhpr0807774 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040038659
213 rdf:type schema:CreativeWork
214 https://doi.org/10.1056/nejmoa052122 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035589584
215 rdf:type schema:CreativeWork
216 https://doi.org/10.1056/nejmoa052306 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014794593
217 rdf:type schema:CreativeWork
218 https://doi.org/10.1056/nejmoa072113 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033842397
219 rdf:type schema:CreativeWork
220 https://doi.org/10.1056/nejmoa0908127 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010192285
221 rdf:type schema:CreativeWork
222 https://doi.org/10.1056/nejmp0802107 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046285446
223 rdf:type schema:CreativeWork
224 https://doi.org/10.1093/annonc/mdg031 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013830509
225 rdf:type schema:CreativeWork
226 https://doi.org/10.1093/annonc/mdm517 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006759230
227 rdf:type schema:CreativeWork
228 https://doi.org/10.1093/jnci/94.22.1668 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059820988
229 rdf:type schema:CreativeWork
230 https://doi.org/10.1097/00042560-199605010-00008 schema:sameAs https://app.dimensions.ai/details/publication/pub.1060296025
231 rdf:type schema:CreativeWork
232 https://doi.org/10.1136/bmj.a3182 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062800786
233 rdf:type schema:CreativeWork
234 https://doi.org/10.1177/030089160909500601 schema:sameAs https://app.dimensions.ai/details/publication/pub.1078058240
235 rdf:type schema:CreativeWork
236 https://doi.org/10.1200/jco.2006.06.8940 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030184862
237 rdf:type schema:CreativeWork
238 https://doi.org/10.1200/jco.2008.16.9599 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051285514
239 rdf:type schema:CreativeWork
240 https://doi.org/10.1200/jco.2009.26.2758 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042800800
241 rdf:type schema:CreativeWork
242 https://doi.org/10.1200/jco.2010.34.1248 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031741399
243 rdf:type schema:CreativeWork
244 https://doi.org/10.1634/theoncologist.2010-s1-58 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004219720
245 rdf:type schema:CreativeWork
246 https://doi.org/10.3109/07357909109018958 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030428216
247 rdf:type schema:CreativeWork
248 https://doi.org/10.5694/j.1326-5377.2006.tb00689.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1077326340
249 rdf:type schema:CreativeWork
250 https://www.grid.ac/institutes/grid.418322.e schema:alternateName Centro di Riferimento Oncologico della Basilicata
251 schema:name Department of Onco-Hematology, I.R.C.C.S. Centro di Riferimento Oncologico di Basilicata, Rionero in Vulture, PZ, Italy
252 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...